Results 121 to 130 of about 1,053,112 (188)

Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications

open access: yesCancer Cell International
Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer that evades immune surveillance by impairing the NKG2D receptor on natural killer (NK) cells and cytotoxic T lymphocytes.
Parsa Alijanizadeh   +8 more
doaj   +1 more source

CEBPA mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition. [PDF]

open access: yesOncoimmunology, 2022
Liu M   +12 more
europepmc   +1 more source

NKG2D Ligands in Pediatric Cancer [PDF]

open access: yesBiology of Blood and Marrow Transplantation, 2013
Gupta, Neha Das   +4 more
openaire   +1 more source

Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition. [PDF]

open access: yesCell Death Dis, 2021
Petillo S   +13 more
europepmc   +1 more source

Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019. [PDF]

open access: yesYonago Acta Med
Nagamizu K   +11 more
europepmc   +1 more source

Staphylococcus aureus induces cell-surface expression of immune stimulatory NKG2D ligands on human monocytes. [PDF]

open access: yesJ Biol Chem, 2020
Mellergaard M   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy